Aurinia Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.1M | 411k | 5.01 |
| 2023-12-31 | $3.5M | 394k | 8.99 |
| 2023-09-30 | $3.1M | 398k | 7.77 |
| 2023-06-30 | $3.9M | 402k | 9.68 |
| 2023-03-31 | $4.4M | 399k | 10.96 |
| 2022-12-31 | $1.7M | 404k | 4.32 |
| 2022-09-30 | $3.0M | 407k | 7.47 |
| 2022-06-30 | $3.7M | 372k | 10.05 |
| 2021-06-30 | $183k | 14k | 12.88 |
| 2021-03-31 | $678k | 52k | 12.98 |
| 2020-12-31 | $815k | 59k | 13.83 |
| 2017-12-31 | $51k | 12k | 4.35 |
| 2017-06-30 | $502k | 82k | 6.13 |
| 2017-03-31 | $595k | 81k | 7.34 |